Adaptive Partial Drug Approval: A Health Policy Proposal
Charles Manski of Northwestern argues that the drug approval process should be more continuous, so that patients can have access to beneficial drugs earlier and at the same time there are incentives for longer term studies than the current system produces, which could limit problems like those caused by Vioxx.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.